IT1313625B1 - Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina. - Google Patents

Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.

Info

Publication number
IT1313625B1
IT1313625B1 IT1999MI001964A ITMI991964A IT1313625B1 IT 1313625 B1 IT1313625 B1 IT 1313625B1 IT 1999MI001964 A IT1999MI001964 A IT 1999MI001964A IT MI991964 A ITMI991964 A IT MI991964A IT 1313625 B1 IT1313625 B1 IT 1313625B1
Authority
IT
Italy
Prior art keywords
dyerotonin
benzimidazolonic
dopamin
receptors
derivatives
Prior art date
Application number
IT1999MI001964A
Other languages
English (en)
Inventor
Enzo Cereda
Maura Bignotti
Giovanni Battista Schiavi
Original Assignee
Boehringer Ingelheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Italia filed Critical Boehringer Ingelheim Italia
Publication of ITMI991964A0 publication Critical patent/ITMI991964A0/it
Priority to IT1999MI001964A priority Critical patent/IT1313625B1/it
Priority to US09/634,120 priority patent/US6281218B1/en
Priority to CA002381819A priority patent/CA2381819C/en
Priority to DK00965975T priority patent/DK1218352T3/da
Priority to AT00965975T priority patent/ATE266644T1/de
Priority to PCT/EP2000/008891 priority patent/WO2001021593A1/en
Priority to JP2001524972A priority patent/JP4989002B2/ja
Priority to PT00965975T priority patent/PT1218352E/pt
Priority to AU76537/00A priority patent/AU7653700A/en
Priority to EP00965975A priority patent/EP1218352B1/en
Priority to ES00965975T priority patent/ES2220541T3/es
Priority to MXPA02001986A priority patent/MXPA02001986A/es
Priority to DE60010732T priority patent/DE60010732T2/de
Priority to PE2000000977A priority patent/PE20010600A1/es
Priority to CO00071863A priority patent/CO5210864A1/es
Priority to ARP000104963A priority patent/AR025739A1/es
Publication of ITMI991964A1 publication Critical patent/ITMI991964A1/it
Application granted granted Critical
Publication of IT1313625B1 publication Critical patent/IT1313625B1/it
Priority to JP2011226651A priority patent/JP2012067105A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IT1999MI001964A 1999-09-22 1999-09-22 Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina. IT1313625B1 (it)

Priority Applications (17)

Application Number Priority Date Filing Date Title
IT1999MI001964A IT1313625B1 (it) 1999-09-22 1999-09-22 Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
US09/634,120 US6281218B1 (en) 1999-09-22 2000-08-08 Benzimidazolone derivatives having mixed serotonin and dopamine receptors affinity
AU76537/00A AU7653700A (en) 1999-09-22 2000-09-12 New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
MXPA02001986A MXPA02001986A (es) 1999-09-22 2000-09-12 Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina.
AT00965975T ATE266644T1 (de) 1999-09-22 2000-09-12 Benzimidazolonderivate mit affinität für sowohl die serotonin- als auch die dopamin-rezeptoren
PCT/EP2000/008891 WO2001021593A1 (en) 1999-09-22 2000-09-12 New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
JP2001524972A JP4989002B2 (ja) 1999-09-22 2000-09-12 混合したセロトニン及びドーパミン受容体親和性を有する新規ベンズイミダゾロン誘導体
PT00965975T PT1218352E (pt) 1999-09-22 2000-09-12 Novos derivados de benzimidazolona tendo receptores com afinidade mista para os receptores de serotonina e dopamina
CA002381819A CA2381819C (en) 1999-09-22 2000-09-12 New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
EP00965975A EP1218352B1 (en) 1999-09-22 2000-09-12 Benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
ES00965975T ES2220541T3 (es) 1999-09-22 2000-09-12 Derivados de bencimidazolinas con afinidad mixta para receptores de serotonina y dopamina.
DK00965975T DK1218352T3 (da) 1999-09-22 2000-09-12 Benzimidazolonderivater med affinitet for både serotonin- og dopamin-receptorer
DE60010732T DE60010732T2 (de) 1999-09-22 2000-09-12 Benzimidazolonderivate mit affinität für sowohl die serotonin- als auch die dopamin-rezeptoren
PE2000000977A PE20010600A1 (es) 1999-09-22 2000-09-20 Derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina
CO00071863A CO5210864A1 (es) 1999-09-22 2000-09-21 Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina
ARP000104963A AR025739A1 (es) 1999-09-22 2000-09-22 Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina
JP2011226651A JP2012067105A (ja) 1999-09-22 2011-10-14 混合したセロトニン及びドーパミン受容体親和性を有する新規ベンズイミダゾロン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001964A IT1313625B1 (it) 1999-09-22 1999-09-22 Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.

Publications (3)

Publication Number Publication Date
ITMI991964A0 ITMI991964A0 (it) 1999-09-22
ITMI991964A1 ITMI991964A1 (it) 2001-03-22
IT1313625B1 true IT1313625B1 (it) 2002-09-09

Family

ID=11383635

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001964A IT1313625B1 (it) 1999-09-22 1999-09-22 Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.

Country Status (16)

Country Link
US (1) US6281218B1 (it)
EP (1) EP1218352B1 (it)
JP (2) JP4989002B2 (it)
AR (1) AR025739A1 (it)
AT (1) ATE266644T1 (it)
AU (1) AU7653700A (it)
CA (1) CA2381819C (it)
CO (1) CO5210864A1 (it)
DE (1) DE60010732T2 (it)
DK (1) DK1218352T3 (it)
ES (1) ES2220541T3 (it)
IT (1) IT1313625B1 (it)
MX (1) MXPA02001986A (it)
PE (1) PE20010600A1 (it)
PT (1) PT1218352E (it)
WO (1) WO2001021593A1 (it)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
US7183410B2 (en) * 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
US20030060475A1 (en) * 2001-08-10 2003-03-27 Boehringer Ingelheim Pharma Kg Method of using flibanserin for neuroprotection
UA78974C2 (en) * 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US7033345B2 (en) * 2002-05-21 2006-04-25 Advanced Cardiovascular Systems, Inc. Deflectable microimplant delivery system
US20040048877A1 (en) * 2002-05-22 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions containing flibanserin
EP1664042A1 (en) * 2003-09-03 2006-06-07 Galapagos N.V. IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
US20050215589A1 (en) * 2003-09-03 2005-09-29 Roger Crossley Inhibitors of 5-HT2A receptor
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US20050239798A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the treatment of premenstrual and other female sexual disorders
KR20070014184A (ko) * 2004-04-22 2007-01-31 베링거 인겔하임 인터내셔날 게엠베하 성기능 장애 치료용 신규 약제학적 조성물 ⅱ
US20060025420A1 (en) * 2004-07-30 2006-02-02 Boehringer Ingelheimn International GmbH Pharmaceutical compositions for the treatment of female sexual disorders
JP2008511569A (ja) * 2004-09-03 2008-04-17 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 注意欠如活動過多障害の治療方法
WO2006052640A1 (en) * 2004-11-05 2006-05-18 Theravance, Inc. 5-ht4 receptor agonist compounds
ES2327142T3 (es) * 2004-11-05 2009-10-26 Theravance, Inc. Compuestos de quinolinona-carboxamida.
NZ555180A (en) * 2004-12-22 2010-09-30 Theravance Inc Indazole-carboxamide compounds useful as 5-HT4 receptor agonists
NZ560828A (en) * 2005-03-02 2011-01-28 Theravance Inc Quinolinone compounds as 5-HT4 receptor agonists
WO2006096439A2 (en) * 2005-03-04 2006-09-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
JP2008531714A (ja) * 2005-03-04 2008-08-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 不安障害の治療用及び／又は予防用の医薬組成物
US20060211685A1 (en) * 2005-03-04 2006-09-21 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for the treatment and/or prevention of depression
JP2008540356A (ja) * 2005-05-06 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 薬物乱用の治療方法
EP1888070A1 (en) * 2005-05-19 2008-02-20 Boehringer Ingelheim International GmbH Method for the treatment of sexual dysfunctions due to medical conditions
WO2006125042A1 (en) * 2005-05-19 2006-11-23 Boehringer Ingelheim International Gmbh Method for the treatment of drug-induced sexual dysfunction
ATE495171T1 (de) * 2005-06-07 2011-01-15 Theravance Inc Benzimidazoloncarbonsäureamidverbindungen als agonisten des 5-ht4-rezeptors
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
US20070123540A1 (en) * 2005-10-29 2007-05-31 Angelo Ceci Sexual desire enhancing medicaments comprising benzimidazolone derivatives
US7923449B2 (en) * 2005-10-29 2011-04-12 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20070105869A1 (en) * 2005-11-08 2007-05-10 Stephane Pollentier Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
MY143574A (en) * 2005-11-22 2011-05-31 Theravance Inc Carbamate compounds as 5-ht4 receptor agonists
JP2009527525A (ja) * 2006-02-20 2009-07-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁治療用のベンゾイミダゾロン誘導体
EA200802208A1 (ru) * 2006-05-09 2009-04-28 Бёрингер Ингельхайм Интернациональ Гмбх Применение флибансерина для лечения расстройств полового влечения в постклимактерический период
ES2336719T3 (es) 2006-06-30 2010-04-15 Boehringer Ingelheim International Gmbh Flibanserina para el tratamiento de la incontinencia urinaria y las enfermedades relacionadas.
CA2657043A1 (en) * 2006-07-14 2008-01-17 Boehringer Ingelheim International Gmbh Use of flibanserin for the treatment of sexual disorders in females
CL2007002214A1 (es) * 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
CA2660476C (en) * 2006-08-14 2015-11-17 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
CA2661613C (en) * 2006-08-25 2016-01-26 Boehringer Ingelheim International Gmbh Controlled release system and method for manufacturing the same
WO2008061968A1 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim International Gmbh Benzimidazolone derivates in the treatment of pulmonary arterial hypertension
EP2097389B1 (en) 2006-12-20 2011-09-14 Boehringer Ingelheim International GmbH Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity
WO2008090742A1 (ja) * 2007-01-23 2008-07-31 National University Corporation Hokkaido University 眼疾患モデル用非ヒト動物
UY31335A1 (es) * 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
EP2238117A1 (en) * 2008-01-24 2010-10-13 NeuroSearch A/S 4-phenyl-piperazin-1-yl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251144B (it) * 1991-07-30 1995-05-04 Boehringer Ingelheim Italia Derivati del benzimidazolone
IT1313625B1 (it) * 1999-09-22 2002-09-09 Boehringer Ingelheim Italia Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.

Also Published As

Publication number Publication date
MXPA02001986A (es) 2002-10-31
ITMI991964A0 (it) 1999-09-22
ES2220541T3 (es) 2004-12-16
PT1218352E (pt) 2004-09-30
JP2012067105A (ja) 2012-04-05
DE60010732D1 (de) 2004-06-17
DE60010732T2 (de) 2005-05-25
JP2003509496A (ja) 2003-03-11
ITMI991964A1 (it) 2001-03-22
EP1218352B1 (en) 2004-05-12
CA2381819A1 (en) 2001-03-29
JP4989002B2 (ja) 2012-08-01
US6281218B1 (en) 2001-08-28
AU7653700A (en) 2001-04-24
ATE266644T1 (de) 2004-05-15
AR025739A1 (es) 2002-12-11
DK1218352T3 (da) 2004-06-28
CO5210864A1 (es) 2002-10-30
EP1218352A1 (en) 2002-07-03
CA2381819C (en) 2007-03-13
PE20010600A1 (es) 2001-06-04
WO2001021593A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
IT1313625B1 (it) Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
ATE380793T1 (de) N-phenyl-alkylsulfonamid-derivate, deren herstellung und deren verwendung als alpha1a/1l- adrenoceptor agonisten
DE59911249D1 (de) Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung
BR9711970A (pt) Derivados 6,5-substitu¡do-heterobic¡clicos
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
AU4337699A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT4 receptors
DE69928945D1 (de) 4,4-biarylpiperidinederivate mit opioid-receptor-wirkung
FI970310A (fi) 4-indolijohdannaiset serotoniinin vaikuttaja- ja vastavaikuttaja-aineina
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
DE69838323D1 (de) Dieselzusatz zur cetan-,schmiereigenschaft- und stabilitätverbesserung
DE59912473D1 (de) 2-phenylbenzimidazole und 2-phenylindole, deren herstellung und anwendung
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
IS4813A (is) Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka
ID26639A (id) Sediaan farmasi yang mengandung agonis reseptor angiotensin ii jenis 2 dan pemakaiannya
ATE260033T1 (de) Biozide zusammensetzung und deren verwendung
MA24736A1 (fr) Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques
DE59800439D1 (de) Vernetzbare, in Wasser redispergierbare Pulverzusammensetzung
EE200100347A (et) 3,3-biarüülpiperidiini ja 2,2-biarüülmorfoliini derivaadid
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
NO20003825D0 (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
ATE353881T1 (de) 1,4-diazepan-2,5-dion-derivate und deren verwendung als nk-1 rezeptorantagonisten
DE975695T1 (de) Zusammensetzungen, enthaltend gleit- und antiblockmittel
DE69908371D1 (de) Thioethergruppen enthaltende distamycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
BR9711273A (pt) 1,2,3,4- Tetraidro-2-dibenzofuranaminas substituidas e 2- aminociclohepta b benzofuranos